SMFM · ACOG · Clinical Practice

Universal Cervical Length
Screening

Prevention of Spontaneous Preterm Birth

Evidence-Based Guideline Review
Maternal-Fetal Medicine · DoctorsWhoCode.blog
Atlanta Perinatal Associates
Epidemiology

The Burden of Preterm Birth

10%
US births are preterm
#1
Cause of neonatal mortality
50%
sPTB occurs in low-risk patients
$26B
Annual US economic burden
The majority of spontaneous preterm births occur in patients without a prior history — making universal screening clinically essential.
Atlanta Perinatal Associates
Diagnostic Tool

The Primary Clinical Predictor

Transvaginal Ultrasound (TVUS)
  • Gold standard for CL measurement Grade 1C
  • Directly visualizes the internal os
  • Superior sensitivity to transabdominal approach
  • Standardized per PQF / CLEAR protocol
Transabdominal Ultrasound
  • Lacks sensitivity for internal os
  • May overstate CL with full bladder
  • Not recommended as screening tool
  • Acceptable only if TVUS unavailable
Atlanta Perinatal Associates
Timing

Optimal Screening Window

14
≤16 wks
Low predictive
value — not
recommended
16
16 wks
Start serial
screening
(prior sPTB)
18
18–24 wks
Anatomy scan
universal
screening
24
24 wks
Intervention
benefit
diminishes
28
>24 wks
Routine
screening not
recommended
Screening before 16 weeks has low predictive value. Routine screening after 24 weeks is not recommended for asymptomatic patients.
Atlanta Perinatal Associates
ACOG · SMFM Guidelines

Screening by Obstetric History

Parameter Prior Spontaneous PTB No Prior Spontaneous PTB
Recommendation Recommended — Serial TVUS May be considered — Universal
Gestational Age 160/7 – 240/7 weeks 180/7 – 240/7 weeks
Frequency Every 1–2 weeks Single midtrimester assessment
Short Cervix Threshold ≤25 mm ≤25 mm (intervention at ≤20 mm)
Primary Intervention Cerclage or Vaginal Progesterone Vaginal Progesterone if CL ≤20 mm
Atlanta Perinatal Associates
Diagnostic Criteria

Defining the Short Cervix

20 mm
25 mm
0 mm 15 mm 30 mm 45 mm 60 mm
Very High Risk
High Risk — Intervene
Lower Risk
≤25 mm — "Short Cervix"
  • Diagnostic threshold for all patients
  • Triggers clinical action and counseling
  • Applies to both high- and low-risk groups
≤20 mm — Intervention Threshold
  • Vaginal progesterone indicated Grade 1C
  • Applies to asymptomatic singletons without prior sPTB
  • Must be identified before 240/7 weeks
Atlanta Perinatal Associates
Meta-Analytic Evidence

Impact of Universal Screening

OR 0.84
Reduction in sPTB <32 wks
95% CI 0.76–0.94
OR 0.88
Reduction in sPTB <37 wks
95% CI 0.79–0.97
↓
Neonatal morbidity in low-risk cohorts
Key Finding — Population Impact
Universal screening programs demonstrate a greater impact on early sPTB (<28 and <32 weeks) compared to late sPTB, with associated reductions in threatened preterm labor and neonatal morbidity.
Atlanta Perinatal Associates
Management

Vaginal Progesterone

✓
Indicated
Singleton, no prior sPTB, CL ≤20 mm before 24 wks
📉
Reduces sPTB
Decreases preterm birth and neonatal morbidity
💊
Route Matters
Vaginal formulation — not IM 17-OHPC for this indication
⏱
Time-Sensitive
Must initiate before 240/7 weeks for benefit
SMFM Guidance · Grade 1C
Vaginal progesterone reduces the risk of sPTB and neonatal morbidity in asymptomatic singleton gestations with a midtrimester CL ≤20 mm.
Atlanta Perinatal Associates
Management

Cerclage: When Is It Indicated?

Cerclage IS Indicated
  • Prior sPTB + short cervix identified on serial screening
  • History-indicated cerclage (3+ prior PTBs or LEEP)
  • Physical exam-indicated (dilated cervix in 2nd trimester)
Cerclage NOT Indicated
  • Short cervix alone without prior sPTB history
  • No demonstrated benefit over vaginal progesterone in this subgroup
  • Multiple gestations with short cervix
For asymptomatic singletons without prior sPTB and CL ≤20 mm — vaginal progesterone is the preferred intervention, not cerclage.
Atlanta Perinatal Associates
Special Populations

Multiple Gestations

⚠
Not Recommended
Routine CL screening for twins — SMFM guidance
✗
No Benefit
Progesterone has not demonstrated benefit in unselected twin gestations
✗
Cerclage Ineffective
No adequate clinical benefit in twin pregnancies with short cervix
Clinical Note
Interventions effective in singleton gestations do not translate to multiple pregnancies. Management of twins with short cervix requires individualized clinical judgment.
Atlanta Perinatal Associates
Implementation

Disparities & Documentation

Screening Disparities
  • Patients declining screening more likely to be African American, have obesity, smoke, or be multiparous
  • These populations carry higher baseline sPTB risk
  • aOR 2.01 for sPTB <28 wks among those who declined
Required Documentation
  • Method: TVUS confirmed
  • Measurement: shortest of three consistent values
  • No fundal pressure applied during scan
  • Bladder empty at time of measurement
Atlanta Perinatal Associates
Health Economics

Cost-Effectiveness of Universal Screening

💰
Cost-Effective
Universal CL screening + vaginal progesterone is a cost-effective strategy
🏥
NICU Savings
Reduces neonatal morbidity and associated NICU expenditures
📊
Modeling Support
Economic modeling confirms population-level benefit of universal programs
Clinical Implication
The cost of a single TVUS measurement at the anatomy scan is far outweighed by the potential savings from preventing even one early preterm birth and its associated neonatal complications.
Atlanta Perinatal Associates
Clinical Decision Support

Management Algorithm

Clinical Scenario CL Finding Recommended Action Evidence
Singleton, no prior sPTB CL >25 mm Routine obstetric care Standard
Singleton, no prior sPTB CL 21–25 mm Counsel; consider repeat TVUS Consensus
Singleton, no prior sPTB CL ≤20 mm Vaginal progesterone Grade 1C
Singleton, prior sPTB CL ≤25 mm Cerclage or vaginal progesterone Grade 1B
Multiple gestation Any CL Individualized management; no routine intervention Consensus
Atlanta Perinatal Associates
Summary

Key Takeaways

Screen
  • TVUS is the gold standard — not transabdominal
  • Universal screening at 18–24 weeks is reasonable for all singletons
  • Serial screening from 16 weeks for prior sPTB
Intervene
  • CL ≤20 mm in singleton without prior sPTB → vaginal progesterone
  • CL ≤25 mm with prior sPTB → cerclage or progesterone
  • Intervene before 240/7 weeks for maximum benefit
Universal CL screening is a cost-effective, evidence-supported strategy to identify and treat asymptomatic patients at risk for spontaneous preterm birth.
Atlanta Perinatal Associates
Sources

Guideline References

Organization Document Topic
ACOG Practice Bulletin #142 Cerclage for management of cervical insufficiency
SMFM Consult Series #52 Progesterone and preterm birth prevention
SMFM Consult Series #30 Cervical length screening for prevention of preterm birth
ACOG / SMFM Obstetric Care Consensus #1 Safe prevention of the primary cesarean delivery
Perinatal Quality Foundation CLEAR Program Standardized cervical length measurement protocol
Romero et al. AJOG 2016 Vaginal progesterone in asymptomatic women with short cervix
Atlanta Perinatal Associates
← OpenMFM Library